Vaxart VXRT
OTC VXRT
$0.36 -0.02 (-5.26%)
At close: Nov 10, 2026 · 4:00 PM EST

Vaxart (VXRT) Deferred Taxes (2012 - 2013)

Updated

Vaxart (VXRT) recorded Deferred Taxes of -$1.1 million in Q4 2013.

Analysis

Vaxart (VXRT) Deferred Taxes (2012 - 2013) Analysis & Trends

For FY2013, Vaxart reported Deferred Taxes of -$1.5 million.

  • Across earlier years, Deferred Taxes came in at -$671,000 in FY2012 and -$2.02 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.79 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -56.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 202.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -860.00 Mn
10 Vaxart 87.73 Mn 22.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 1.10 Mn
Dec 31, 2012 500,000.00
Sep 30, 2012 -100,000.00
Mar 31, 2012 -671,000.00
API Access

Vaxart Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=VXRT&period=max&api_key=YOUR_API_KEY